FierceBiotech

ADA: Medtronic's next-gen artificial pancreas algorithm boosts time in range for young adults with Type 1 diabetes

A new version of Medtronic’s advanced, hybrid closed-loop insulin delivery system showed it could help improve blood sugar control throughout the day in adolescents and young adults with Type 1 ...
FierceBiotech

ADA: With promising long-term data for its artificial pancreas, Medtronic aims to fully close the diabetes management loop

In just the last few years, diabetes technology has grown exponentially smarter. Top of mind now for many devicemakers is the creation of a truly closed-loop system for insulin delivery—a system often ...
Medscape

ADA 2026 Standards of Care Target Implementation, Policy

Wider use of continuous glucose monitoring (CGM), glycemic management during cancer treatment, and individualized dosing of obesity drugs in people with diabetes are just a few of the new topics and ...
FiercePharma

ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar

Sanofi’s Soliqua combines an insulin with a GLP-1 agonist, and, according to a new real-world study, delivering those two therapies simultaneously is the way to go. Starting an insulin and a GLP-1 ...
Healio

Large differences observed among insulin algorithms at US academic hospitals

Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...
Business Wire

Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase its expanding focus on Dexcom CGM ...